CMS Open Payments · Program Year 2024
Astellas US LLC
Astellas US LLC reported $13,660.17 across General Payments, Research, and Ownership to 20 physicians and teaching hospitals across 20 transactions.
- $13.7K
- All-tracks total
- 20
- Transactions
- 20
- Recipients
- #1590
- of 1,925 companies
Astellas US LLC reported $13,660.17 across all CMS Open Payments tracks (General + Research + Ownership) to 20 physicians and teaching hospitals in Program Year 2024 - ranking #1590 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $13,660.17, averaging $683.01 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer astellas-us-llc Astellas US LLC
$13.7K · #1590/1,925 · 0.0% industry · PY2024
- TOT $13.7K
- RANK #1590
- SHARE 0.0%
- TXN 20
- RCP 20
- CAT 2
- GEN $13.7K
- TOP1 52.7%
- PY 2024
Volume peers
Nearest volume peer: Cardiac Dimensions, Inc. ($13.8K)
Astellas US LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Astellas US LLC
In Program Year 2024, Astellas US LLC reported $13,660.17 in payments to 20 physicians and teaching hospitals across 20 individual transactions, an average of $683.01 per transaction and $683.01 per recipient. That total places Astellas US LLC at rank #1590 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
2 transactions worth $12.0K make "Consulting Fee" the top general-payment category in the 2-category breakdown below, 87.8% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 2 types of general payments, Astellas US LLC's largest category was "Consulting Fee" at $12.0K - 87.8% of General Payments.
How Astellas US LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $12.0K | 2 | 87.8% |
| Food and Beverage | $1.7K | 18 | 12.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $12,407.16 (90.8%) of $13,660.17 in this company's General Payments records across 20 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Astellas US LLC
The five named recipients with the highest reported General Payments from this company
- 1
Wendy Goodall Mcdonald
$7,200.00 across 1 reported transactions
- 2
Joseph Renzulli
$4,800.00 across 1 reported transactions
- 3
Haroon Chaudhry
$135.72 across 1 reported transactions
- 4
Mary Yackey
$135.72 across 1 reported transactions
- 5
Robert Sisk
$135.72 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Astellas US LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Astellas US LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Astellas US LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
RMC Orthopedic & Surgical, Inc.
Myocardial Solutions, Inc.
Transcend
Breas Medical, Inc.
Cutting Edge Spine, LLC
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.